These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10066128)

  • 21. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs.
    Alvarez L; Lifschitz A; Entrocasso C; Manazza J; Mottier L; Borda B; Virkel G; Lanusse C
    J Vet Pharmacol Ther; 2008 Jun; 31(3):230-9. PubMed ID: 18471144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative bioavailability of rafoxanide following intraruminal and intra-abomasal administration in sheep.
    Swan GE; Koeleman HA; Steyn HS; Mülders MS
    J S Afr Vet Assoc; 1999 Jun; 70(2):71-4. PubMed ID: 10855825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes.
    Gokbulut C; Cirak VY; Senlik B
    Vet Res Commun; 2006 Oct; 30(7):791-805. PubMed ID: 17004041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.
    Goudah A
    Vet Res Commun; 2003 Oct; 27(7):555-66. PubMed ID: 14609267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics in sheep and cattle of albendazole administered by an intraruminal slow release capsule.
    Delatour P; Benoit E; Lechenet J; Besse S
    Res Vet Sci; 1990 May; 48(3):271-5. PubMed ID: 2359877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-dependent activity of albendazole against benzimidazole-resistant nematodes in sheep: relationship between pharmacokinetics and efficacy.
    Moreno L; Echevarria F; Muñoz F; Alvarez L; Sanchez Bruni S; Lanusse C
    Exp Parasitol; 2004; 106(3-4):150-7. PubMed ID: 15172222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of surfactants on oral bioavailability of albendazole based on the formation of the sulphoxide metabolites in rats.
    Redondo PA; Alvarez AI; García JL; Villaverde C; Prieto JG
    Biopharm Drug Dispos; 1998 Jan; 19(1):65-70. PubMed ID: 9510986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition kinetics of albendazole in buffalo and cattle.
    Sanyal PK
    J Vet Pharmacol Ther; 1997 Jun; 20(3):240-2. PubMed ID: 9185092
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics and tissue residues of hydrochloric acid albendazole sulfoxide and its metabolites in crucian carp (Carassius auratus) after oral administration.
    Li Z; Chen C; Ai D; Wang C; Li J; Qi Y; Yi W; Shen H; Cao J
    Environ Toxicol Pharmacol; 2012 Mar; 33(2):197-204. PubMed ID: 22227164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diet-induced modulation of pharmacokinetics of albendazole in Sahiwal cattle.
    Sanyal PK; Rawte D; Kerketta AE; Kumbhakar NK; Kumar D; Pal S; Baghel KR; Bisen S
    J Helminthol; 2016 Sep; 90(5):555-60. PubMed ID: 26306773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs.
    Gokbulut C; Bilgili A; Hanedan B; McKellar QA
    Vet Parasitol; 2007 Sep; 148(3-4):279-87. PubMed ID: 17673370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dose increase or cimetidine co-administration on albendazole bioavailability.
    Schipper HG; Koopmans RP; Nagy J; Butter JJ; Kager PA; Van Boxtel CJ
    Am J Trop Med Hyg; 2000; 63(5-6):270-3. PubMed ID: 11421376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats.
    Capece BP; Castells G; Godoy C; Arboix M; Cristòfol C
    Vet J; 2008 Aug; 177(2):297-9. PubMed ID: 17566773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pharmacology-based comparison of the activity of albendazole and flubendazole against Echinococcus granulosus metacestode in sheep.
    Ceballos L; Virkel G; Elissondo C; Canton C; Canevari J; Murno G; Denegri G; Lanusse C; Alvarez L
    Acta Trop; 2013 Sep; 127(3):216-25. PubMed ID: 23692888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified plasma and abomasal disposition of albendazole in nematode-infected sheep.
    Alvarez LI; Sánchez SF; Lanusse CE
    Vet Parasitol; 1997 May; 69(3-4):241-53. PubMed ID: 9195734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative pharmacokinetics of netobimin metabolites in pregnant ewes.
    Cristòfol C; Franquelo C; Navarro M; Carretero A; Ruberte J; Arboix M
    Res Vet Sci; 1997; 62(2):117-20. PubMed ID: 9243708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2003 Jul; 24(5):199-204. PubMed ID: 12784319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the dose-regime.
    López-García ML; Torrado S; Torrado S; Martínez AR; Bolás F
    Vet Parasitol; 1998 Feb; 75(2-3):209-19. PubMed ID: 9637222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ricobendazole kinetics and availability following subcutaneous administration of a novel injectable formulation to calves.
    Lanusse CE; Virkel GL; Sanchez SF; Alvarez LI; Lifschitz AL; Imperiale F; Monfrinotti A
    Res Vet Sci; 1998; 65(1):5-10. PubMed ID: 9769065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-dependent systemic exposure of albendazole metabolites in lambs.
    Alvarez L; Suárez G; Ceballos L; Moreno L; Lanusse C
    J Vet Pharmacol Ther; 2012 Aug; 35(4):365-72. PubMed ID: 21819410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.